How AMH testing and AI counseling might help women plan family and ease fertility worries
Official title: Women Rise, Families Thrive: Advancing Women's Health and Fertility Awareness Through Ovarian Reserve Assessment in Hong Kong
Run by City University of Hong Kong · NCT07894302 · Data updated 2026-11-12
This study tests whether AMH blood testing plus AI-guided counseling or traditional education can improve fertility understanding and reduce anxiety among women aged 25–38 in Hong Kong.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 25 Years to 38 Years |
| Sex | Women only |
| Enrollment | 600 (estimated) |
| Sponsor | City University of Hong Kong Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Hong Kong, Kowloon) |
| Status | Recruiting |
| Started | March 31, 2026 |
| Main results expected | May 30, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | October 26, 2026 |
| Trial ID | NCT07894302 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Biologically female individuals aged 25–38 who are fluent in Chinese or English and have internet access, with no pregnancy, breastfeeding, major psychiatric/cognitive illness, gynecological cancer history, or current gonadotoxic treatment.
✕Probably not a fit
Participants without improvements in comprehension or anxiety reduction may not experience benefit from the intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study examines whether preventive ovarian reserve screening using AMH testing, combined with AI-enabled counseling, improves fertility knowledge and lowers reproductive anxiety compared with standard health education. Participants are 25 to 38 years old women in Hong Kong, allocated to AMH testing with AI counseling delivered by an interactive agent or a static report, versus standard education alone. The design uses a 2x2 framework with propensity score matching and randomized elements to compare comprehension, anxiety, and reproductive intentions at baseline and 2–4 weeks follow-up. Outcomes include medical understanding, STAI-6 anxiety scores, and patient enablement. The trial aims to inform future public health screening policies and addressing psychological barriers to family planning.
Why it matters
Potential benefit: If successful, participants may achieve greater clarity about fertility status and reduced anxiety, potentially supporting informed family planning decisions.
How similar studies have gone: Previous work suggests AI-enabled health communication can improve understanding, but this approach combining AMH screening with AI counseling in this context is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Biologically female (assigned female at birth, with intact ovaries) * Aged 25 to 38 years * Fluent in written and spoken Chinese (Traditional or Simplified) or English * Has access to an internet-enabled smartphone or computer * Able to give electronic or written informed consent Exclusion Criteria: * Currently pregnant or breastfeeding * Known active, severe psychiatric or cognitive disorder that prevents informed - consent or completing the questionnaire * History of gynecological cancer * Currently receiving gonadotoxic chemotherapy or pelvic radiotherapy
Where it's running
-
City University of Hong Kong
Hong Kong, Kowloon, Hong Kong Recruiting
Study contacts
- Study coordinator: Wai-Kit MING, PhD
- Email: wkming2@cityu.edu.hk
- Phone: +852 3442-6956
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ovarian Reserve After Cystectomy for Endometriotic vs. Non-Endometriotic Cysts
This study tests how laparoscopic removal of ovarian cysts affects ovarian reserve in women with endometriotic cysts compared to benign/non-endometriotic cysts.
-
Family-building support for young women after cancer
This pilot tests whether a nurse-delivered four-session videoconference program helps young female cancer survivors make informed, values-based decisions about having children.
-
Deep posterior endometriosis surgery and ovarian reserve
This trial will test whether surgery for severe deep posterior endometriosis changes ovarian reserve in women aged 18 to 39 who do not have ovarian endometriomas.
-
Low-dose hCG priming before IVF for women with diminished ovarian reserve
This trial will test whether daily low-dose hCG injections for eight weeks before a second IVF/ICSI cycle help women with diminished ovarian reserve produce more eggs.
-
Testing a multi-level family planning program called Family Health = Family Wealth
This trial tests whether a community-based program can help couples in Uganda who want to delay pregnancy start and keep using effective contraception over 24 months.
-
In vitro maturation of human eggs for fertility treatment
This study is testing a new way to help women with fertility issues by maturing their eggs in the lab with fewer hormones to see if it makes treatment easier and safer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.